MOI, PAOLO
MOI, PAOLO
Istituto di Ricerca Genetica e Biomedica - IRGB
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
2022 Boulad, Farid; Maggio, Aurelio; Wang, Xiuyan; Moi, Paolo; Acuto, Santina; Kogel, Friederike; Takpradit, Chayamon; Prockop, Susan; Mansilla-Soto, Jorge; Cabriolu, Annalisa; Odak, Ashlesha; Qu, Jinrong; Thummar, Keyur; Du, Fang; Shen, Lingbo; Raso, Simona; Barone, Rita; Di Maggio, Rosario; Pitrolo, Lorella; Giambona, Antonino; Mingoia, Maura; Everett, John K.; Hokama, Pascha; Roche, Aoife M.; Cantu, Vito Adrian; Adhikari, Hriju; Reddy, Shantan; Bouhassira, Eric; Mohandas, Narla; Bushman, Frederic D.; Rivière, Isabelle; Sadelain, Michel
A New Intronic Variant in ECEL1 in Two Patients with Distal Arthrogryposis Type 5D
2021 Alesi, Viola; Sessini, Francesca; Genovese, Silvia; Calvieri, Giusy; Sallicandro, Ester; Ciocca, Laura; Mingoia, Maura; Novelli, Antonio; Moi, Paolo
Normal postnatal outcome in an r(X) mosaic male fetus with retained XIST gene
2021 Mingoia, M.; Sessini, F.; Gasperini, D.; Moi, P.
Induction of therapeutic levels of HbF in genome-edited primary beta(0)39-thalassaemia haematopoietic stem and progenitor cells
2020 Mingoia, Maura; Caria Cristian, A; Ye, Lin; Asunis, Isadora; Marongiu, M Franca; Manunza, Laura; Sollaino, M Carla; Wang, Jiaming; Cabriolu, Annalisa; Kurita, Ryo; Nakamura, Yukio; Cucca, Francesco; Kan Yuet, W; Marini, M Giuseppina; Moi, Paolo
Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment
2017 Caocci G.; Orofino M.G.; Vacca A.; Piroddi A.; Piras E.; Addari M.C.; Caria R.; Pilia M.P.; Origa R.; Moi P.; La Nasa G.
Current growth patterns in children and adolescents with thalassemia major
2016 Origa, R; Danjou, F; Orecchia, V; Zappu, A; Dessi, C; Foschini, Ml; Leoni, Gb; Moi, P; Morittu, M; Demurtas, A; Loche, S
Deferasirox and children: From clinical trials to the real world
2016 Origa R.; Zappu A.; Foschini M.L.; Leoni G.; Morittu M.; Moi P.; Corpino M.; Dessi C.
A genetic score for the prediction of beta-thalassemia severity
2015 Danjou, F; Francavilla, M; Anni, F; Satta, S; Demartis, Fr; Perseu, L; Manca, M; Sollaino, Mc; Manunza, L; Mereu, E; Marceddu, G; Pissard, S; Joly, P; Thuret, I; Origa, R; Borg, J; Forni, Gl; Piga, A; Lai, Me; Badens, C; Moi, P; Galanello, R
Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin
2011 Satta, S; Perseu, L; Moi, P; Asunis, I; Cabriolu, A; Maccioni, L; Demartis, Fr; Manunza, L; Cao, A; Galanello, R
A novel missense mutation (C84R) in a patient with type II vitamin d-dependent rickets.
2010 Asunis I; Marini MG; Porcu L; Meloni A; Cabriolu AL; Cao A; Moi P.
DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region
2010 Bellini, I; Pitto, L; Marini, M; Porcu, L; Moi, P; Garritano, S; Boldrini, L; Rainaldi, G; Fontanini, G; Chiarugi, M; Barale, R; Gemignani, F; Landi, S
Regulation of the human HBA genes by KLF4 in erythroid cell lines.
2010 Marini, Mg; Porcu, L; Asunis, I; Loi, Mg; Ristaldi, Ms; Porcu, S; Ikuta, T; Cao, A; Moi, P
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
2008 Manuela Uda; Renzo Galanello; Serena Sanna; Guillaume Lettre; Vijay G. Sankaran; Weimin Chen; Gianluca Usala; Fabio Busonero; Andrea Maschio; Giuseppe Albai; Maria Grazia Piras; Natascia Sestu; Sandra Lai; Mariano Dei; Antonella Mulas; Laura Crisponi; Silvia Naitza; Isadora Asunis; Manila Deiana; Ramaiah Nagaraja; Lucia Perseu; Stefania Satta; Maria Dolores Cipollina; Carla Sollaino; Paolo Moi; Joel N. Hirschhorn; Stuart H. Orkin; Gonçalo R. Abecasis; David Schlessinger;Antonio Cao
Stem cell engineering for the treatment of severe hemoglobinopathies
2008 Sadelain M; Boulad F; Lisowki L; Moi P;Riviere I
Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells.
2008 Moi P; Sadelain M.
A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF.
2004 Moi, P; Faà, V; Marini, Mg; Asunis, I; Ibba, G; Cao, A; Rosatelli, Mc
The distal beta-globin CACCC box is required for maximal stimulation of the beta-globin gene by EKLF.
2004 Marini MG; Asunis I; Porcu L; Salgo MG; Loi MG; Brucchietti A; Cao A; Moi P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial | 1-gen-2022 | Boulad, Farid; Maggio, Aurelio; Wang, Xiuyan; Moi, Paolo; Acuto, Santina; Kogel, Friederike; Takpradit, Chayamon; Prockop, Susan; Mansilla-Soto, Jorge; Cabriolu, Annalisa; Odak, Ashlesha; Qu, Jinrong; Thummar, Keyur; Du, Fang; Shen, Lingbo; Raso, Simona; Barone, Rita; Di Maggio, Rosario; Pitrolo, Lorella; Giambona, Antonino; Mingoia, Maura; Everett, John K.; Hokama, Pascha; Roche, Aoife M.; Cantu, Vito Adrian; Adhikari, Hriju; Reddy, Shantan; Bouhassira, Eric; Mohandas, Narla; Bushman, Frederic D.; Rivière, Isabelle; Sadelain, Michel | |
| A New Intronic Variant in ECEL1 in Two Patients with Distal Arthrogryposis Type 5D | 1-gen-2021 | Alesi, Viola; Sessini, Francesca; Genovese, Silvia; Calvieri, Giusy; Sallicandro, Ester; Ciocca, Laura; Mingoia, Maura; Novelli, Antonio; Moi, Paolo | |
| Normal postnatal outcome in an r(X) mosaic male fetus with retained XIST gene | 1-gen-2021 | Mingoia, M.; Sessini, F.; Gasperini, D.; Moi, P. | |
| Induction of therapeutic levels of HbF in genome-edited primary beta(0)39-thalassaemia haematopoietic stem and progenitor cells | 1-gen-2020 | Mingoia, Maura; Caria Cristian, A; Ye, Lin; Asunis, Isadora; Marongiu, M Franca; Manunza, Laura; Sollaino, M Carla; Wang, Jiaming; Cabriolu, Annalisa; Kurita, Ryo; Nakamura, Yukio; Cucca, Francesco; Kan Yuet, W; Marini, M Giuseppina; Moi, Paolo | |
| Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment | 1-gen-2017 | Caocci G.; Orofino M.G.; Vacca A.; Piroddi A.; Piras E.; Addari M.C.; Caria R.; Pilia M.P.; Origa R.; Moi P.; La Nasa G. | |
| Current growth patterns in children and adolescents with thalassemia major | 1-gen-2016 | Origa, R; Danjou, F; Orecchia, V; Zappu, A; Dessi, C; Foschini, Ml; Leoni, Gb; Moi, P; Morittu, M; Demurtas, A; Loche, S | |
| Deferasirox and children: From clinical trials to the real world | 1-gen-2016 | Origa R.; Zappu A.; Foschini M.L.; Leoni G.; Morittu M.; Moi P.; Corpino M.; Dessi C. | |
| A genetic score for the prediction of beta-thalassemia severity | 1-gen-2015 | Danjou, F; Francavilla, M; Anni, F; Satta, S; Demartis, Fr; Perseu, L; Manca, M; Sollaino, Mc; Manunza, L; Mereu, E; Marceddu, G; Pissard, S; Joly, P; Thuret, I; Origa, R; Borg, J; Forni, Gl; Piga, A; Lai, Me; Badens, C; Moi, P; Galanello, R | |
| Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin | 1-gen-2011 | Satta, S; Perseu, L; Moi, P; Asunis, I; Cabriolu, A; Maccioni, L; Demartis, Fr; Manunza, L; Cao, A; Galanello, R | |
| A novel missense mutation (C84R) in a patient with type II vitamin d-dependent rickets. | 1-gen-2010 | Asunis I; Marini MG; Porcu L; Meloni A; Cabriolu AL; Cao A; Moi P. | |
| DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region | 1-gen-2010 | Bellini, I; Pitto, L; Marini, M; Porcu, L; Moi, P; Garritano, S; Boldrini, L; Rainaldi, G; Fontanini, G; Chiarugi, M; Barale, R; Gemignani, F; Landi, S | |
| Regulation of the human HBA genes by KLF4 in erythroid cell lines. | 1-gen-2010 | Marini, Mg; Porcu, L; Asunis, I; Loi, Mg; Ristaldi, Ms; Porcu, S; Ikuta, T; Cao, A; Moi, P | |
| Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. | 1-gen-2008 | Manuela Uda; Renzo Galanello; Serena Sanna; Guillaume Lettre; Vijay G. Sankaran; Weimin Chen; Gianluca Usala; Fabio Busonero; Andrea Maschio; Giuseppe Albai; Maria Grazia Piras; Natascia Sestu; Sandra Lai; Mariano Dei; Antonella Mulas; Laura Crisponi; Silvia Naitza; Isadora Asunis; Manila Deiana; Ramaiah Nagaraja; Lucia Perseu; Stefania Satta; Maria Dolores Cipollina; Carla Sollaino; Paolo Moi; Joel N. Hirschhorn; Stuart H. Orkin; Gonçalo R. Abecasis; David Schlessinger;Antonio Cao | |
| Stem cell engineering for the treatment of severe hemoglobinopathies | 1-gen-2008 | Sadelain M; Boulad F; Lisowki L; Moi P;Riviere I | |
| Towards the genetic treatment of beta-thalassemia: new disease models, new vectors, new cells. | 1-gen-2008 | Moi P; Sadelain M. | |
| A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF. | 1-gen-2004 | Moi, P; Faà, V; Marini, Mg; Asunis, I; Ibba, G; Cao, A; Rosatelli, Mc | |
| The distal beta-globin CACCC box is required for maximal stimulation of the beta-globin gene by EKLF. | 1-gen-2004 | Marini MG; Asunis I; Porcu L; Salgo MG; Loi MG; Brucchietti A; Cao A; Moi P. |